EFTA00306883Set 9
2014-06-027p4,747w
J.P.Morgan North America Equity Research
O2 June 2014
Overweight
Merck & Co., Inc. MRK, MRK US
Price: $57.93
Pushing Ahead Aggressively in PD-1 Development
Price Target: $64.00
We attended Merck ... data and development plans for its PD-1 (pembrolizumab). Overall, we increasingly Specialty
see Merck playing a leadership role in the immuno-oncology space given its Chris Schott ... admittedly small indication) with a PDUFA in October. Jessica Fye
(1-212) 622-4165
• Merck confirms PD-I efficacy in IL PD-L1+ NSCLC with 47% irRC ORIL
First data
https://www.justice.gov/epstein/files/DataSet%209/EFTA00306883.pdf
EFTA01103797Set 9
2013-09-2315p5,239w
GlaxoSmithKline
• Bob McMahon, Senior Vice President Government Relations, Public Policy and
Corporate Responsibility, Merck
• Caroline Roan, President, Pfizer Foundation
• Sabina Cosic, Chief Investment Officer, Life Sciences, IFC
• Peter Singer ... fund that you can mention include Sweden, CIFF, KfW, Grand Challenges
Canada, GSK, Merck, Pfizer, IFC and J.P. Morgan
Suggested Talking Points — Meeting with Key Partners:
Following the conclusion ... health goal. Sweden brings their AAA credit rating and their impactful guaranty
program. GSK, Merck and Pfizer are contributing both their capital and their product
development expertise to the Fund
https://www.justice.gov/epstein/files/DataSet%209/EFTA01103797.pdf
EFTA01195776Set 9
2014-01-088p6,422w
allocation.
fects of 10-mg rizatriptan (orally disintegrating melting tablet, brand
name Maxalt-MLT, Merck and Co. Inc.) and placebo treatment (micro- Outcomes O
crystalline cellulose, Merck) on acute migraine ... form at htthWwwwiemje.org/cd_cesclosure.pdf available an request from the corresponding
Functions Primary funding source Merck and Co. Inc. RB. received grant support from Merck author). RB. received research support (gran0 ... this study from Merck and Co. Inc RB was a
and Co. Inc. and from the Null (ROI N5069847, R37 NS079678).T.J.K and J.M.K. were partiaBy member of Merck
https://www.justice.gov/epstein/files/DataSet%209/EFTA01195776.pdf
EFTA00504089Set 9
2018-05-242p470w
back from you
> and hopefully working with you.
•
> Best regards,
> Angalina
> Brand Executive
> Welly Merck Team
> Facebook <http://www.Facebook.com/wellymerckofficial>/Instagram
> <http://www.instagram.com/wellymerck>/*Youtube
> <https://www.youtube.com/c/wellymerck>*
> *https://www.wellymerck.com ... Angalina .‘Z > wrote:
>> Dear,
>> I'm Angalina from Welly Merck, a luxury fashion watch brand from
>> Switzerland. I would like to know if we can do some cooperation with ... brand well. Would you like to be a partner of
EFTA00504089
>> Welly Merck? If you have a minute to learn more about us, you can visit us
>> here
https://www.justice.gov/epstein/files/DataSet%209/EFTA00504089.pdf
EFTA00807234Set 9
2017-09-0129p7,076w
building, ...
Zacks 15-Sep-2017
Tagged entities: Palantir Technologies. Amazon.com Agole, Hershey, PayPal Holdings
Merck & Co.. Inc. (NYSE:MRK) And Palantir Technologies Inc Agree On Cancer Data
Analysis Pact ... 4-traders.com) Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into
a deal that will see them work together on a cancer data analytics ... technology for i...
4-traders 18-Jan-2017
Tagged entities: Palantir Technologies. Merck & Co. New York Stock Exchange
Partnership
(4-traders.com) PALO ALTO, Calif. and DARMSTADT, Germany, Jan. 12, 2017 /PRNewswire
https://www.justice.gov/epstein/files/DataSet%209/EFTA00807234.pdf
EFTA00847263Set 9
2015-09-022p426w
PivIRK Chart
MRK data by YCharts
4. Merck & Co. (MRK)
Credit Suisse Rating, Target Price: Neutral, S61
Potential Stock Upside: 11%
Upcoming Catalyst: MRK's Januvia franchise will likely feel ... action date Jan 28).
TheStreet Rating: Buy, B+
TheStreet Said: TheStreet Ratings team rates MERCK & CO as a Buy with a ratings score of B+. TheStreet
Ratings Team has this ... about their recommendation:
"We rate MERCK & CO (MRK) a BUY. This is driven by several positive factors, which we believe should have
a greater impact than any weaknesses, and should
https://www.justice.gov/epstein/files/DataSet%209/EFTA00847263.pdf
EFTA02686169Set 11
2011-01-1828p14,325w
Rural
Development of Vietnam
Susan Capps Morris Senior Vice-President and Chief of Merck & Co. Inc. USA
Staff to Office of Chief Executive
Officer
Steve Cardell Chief Executive Officer ... Clark Administrator. United Nations
Development Programme (UNDP),
New York
Richard T. Clark Chairman Merck & Co. Inc. USA
Susan M. Clark Director. Corporate Affairs SABMiller plc United Kingdom
Wendy Clark Senior ... George Professor of Management Practice Harvard Business School USA
Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA
David R. Gergen Director, Center for Public Leadership Harvard Kennedy School
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02686169.pdf
EFTA00847215Set 9
2015-09-023p590w
Date: Wed, 02 Sep 2015 15:50:35 +0000
no lets look at buying merck . outright
On Wed, Sep 2, 2015 at 6:28 AM, Richard Kahn < > wrote:
Shall ... Daniel for Merck structured note ideas with 20 percent downside protections.
Please advise.
Thank you.
Sent from my iPhone
On Sep 1, 2015, at 3:59 PM, jeffrey ... sent over an email with the indicative terms for a structured note on Merck. We like the name and would
recommend investing $500k.
MRK is down 11% since August 17th
https://www.justice.gov/epstein/files/DataSet%209/EFTA00847215.pdf